NCT02106949View on ClinicalTrials.gov

Short Message System (SMS) Monitoring Intended for the Suicidal Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

August 20, 2014

Primary Completion Date

March 22, 2019

Study Completion Date

March 22, 2019

Conditions
Patients Having Realized a Suicide Attempt
Interventions
DEVICE

SMS contact with patient after discharge in intervention group

Trial Locations (13)

29609

CHRU de Brest, Brest

35403

CH St Malo, St-Malo

42055

CHU de Saint-Etienne, Hôpital Nord, Saint-Etienne

Unknown

CHU Angers, Angers

CHU Caen, Caen

CHRU Lille, Lille

CHU de Lyon, Lyon

CHU Nantes, Nantes

CH Quimperlé, Quimperlé

CHU Rennes, Rennes

CHU St Nazaire, Saint-Nazaire

CHU Tours, Tours

CH Vannes, Vannes

All Listed Sponsors
collaborator

Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest

UNKNOWN

lead

University Hospital, Brest

OTHER

NCT02106949 - Short Message System (SMS) Monitoring Intended for the Suicidal Patients | Biotech Hunter | Biotech Hunter